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 ABSTRACT:Synthesis of polycyclic compounds having spiro nucleus has attracted the attention of synthetic organic chemists because of their highly pronounced biological activities such as antiviral, 
antimicrobial etc. Therefore, the development of new, rapid, and clean synthetic routes of such compounds is of great importance to both medicinal and synthetic chemists. The 1,3-dipolar-
cycloaddition reactions are proved to be an efficient method for regio and stereo selective synthesis of structurally complex spiro heterocycles from relatively simple precursors. Molecular docking 
provides a consistent and more precise picture of the interaction of biologically active molecules at the receptor level thereby facilitating the designing of novel therapeutic agents. Therefore, potency of 
the spiro compounds (4i) was evaluated preliminary through the molecular docking studies. Later substitutions were made in the reference molecule to get the potent compounds. 
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INTRODUCTION 
Dengue virus (DENV) belongs to the Flavivirus genus of 
the Flaviviridae family and exists as four serotypes: 
DENV-1, DENV-2, DENV-3, and DENV-4[1]. Then latest 
existing of dengue viruses is DENV-5 which has been 
discovered by Normile D. in October 2013. DENV may 
cause an acute illness ranging to mild dengue fever (DF), 
to more severe known as dengue hemorrhagic fever (DHF) 
and dengue shock syndrome (DSS)[2]. DENV is 
transmitted by Aedes mosquitoes, mainly Aedes aegypti 
and to a lesser extent, Aedes albopictus[3-4]. Natural 
products have been a major source for development of new 
drugs and spiro structure is present in many natural 
products[5] . In the past decade, most heterocyclic systems 
have been used as a sources because of nitrogen containing 
heterocyclic systems like novel pyrolidine moieties and 
highly pronounced biological activities such as antiviral, 
antimicrobial potentials[6]. Here in we report the synthesis 
of indanone substituted through cycloaddition reaction that 
generated from acenaphthenequinone and 2-
aminophenylglycine, evaluated their activities and 
predicted the binding mode of the spiro compounds to the 
protein target using molecular docking. 
 
OBJECTIVE 
To design novel spiro compounds as potential antiviral agents  
and study their interaction at the active site of target protein 
through molecular docking.       
 
 
 
EXPERIMENTAL 
 
 
 
 
 
 
 
RESULTS 
 Comp 
Ar M.P.oC 
Rf 
Value 
Yield 
(%) 
4a 3-Nitrophenyl- 144 0.8 61 
4b 4-Dimhetylamino phenyl- 154 0.5 74 
4c 2-Hydrophenyl- 130 0.84 19 
4d 4-(1-Piperidinyl)phenyl- 140 0.76 62 
4e 3-Bromophenyl- 146 0.8 88 
4f 2,4-Dichlorophenyl- 132 0.88 75 
4g 4-Dichlorophenyl- 140 0.8 72 
4h 2-Dichlorophenyl- 180 0.63 87 
4i 4-methoxyphenyl- 170 0.76 59 
4j Phenyl- 160 0.8 77 
4k 4-(4-Morpholinyl)phenyl- 180 0.8 75 
4l 4-trifluoromethoxyphenyl- 180 0.72 55 
Table 1. Physical characteristic of spiro derivatives 4(a-l).   
1H NMR (500 MHz, CDCl3): 2.04 (s, 1H, NH), 
2.60 (s, 2H, CH2), 3.77 (d, 1H, CH), 3.80 (s, 3H, 
OCH3), 4.41 (d, 1H, CH), 6.70-7.92 (m, 19H, ArH). 
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CONCLUSION 
In this study spiro derivatives were found to be inhibitors of 
NS2B-NS3 proteases of the Dengue virus with ki value of 
1.95 μM. Analysis of molecular docking studies help to 
understand the mechanism of inhibition of the Dengue virus 
serine protease by spiro compounds, which is essential for the 
development of improved inhibitors. 
 
 
MOLECULAR DOCKING 
Figure 1: NS2B-NS3 is a serine protease of the Dengue 
virus considered a key target in the search for new 
antiviral drugs. (PDB CODE: 3U1I)9 
Figure 3: 2D  binding interactions of  
compound 4i at  active site showing one H-
bonding with Lys 26 (2.26) 
Figure 2: Binding modes of 4i at the active site of 3U1I.  
Binding energy was found to be  -7.79 kcal/mol and  
inhibition constant ki was found to be 1.95 μM. 
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